DIAMEDICA THERAPEUTICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$9.25
-2.84%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+10.8%
3 months
+41.9%
6 months
+49.7%
1 year
+32.1%
Year to date
+16.2%
52-week range
$5.33 – $9.82
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$498.8M
P/E
-13.3
P/B
13
P/S
—
Revenue
$0
Net income
-$37.59M
Diluted EPS
-0.72
Gross margin
—
Net margin
—
Return on equity
-77.80%
Total debt
$185K
Cash
$5.13M
Free cash flow
-$31.54M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$10.15M | — | — | -$8.12M |
| Mar 31, 2026 | $0 | -$10.12M | — | — | -$9.09M |
| Dec 31, 2025 | $0 | -$8.77M | — | — | -$7.77M |
| Sep 30, 2025 | $0 | -$8.56M | — | — | -$6.57M |
| Jun 30, 2025 | $0 | -$7.72M | — | — | -$7.6M |
| Mar 31, 2025 | $0 | -$7.73M | — | — | -$7.16M |
| Dec 31, 2024 | $0 | -$7.98M | — | — | -$6.44M |
| Sep 30, 2024 | $0 | -$6.14M | — | — | -$4.48M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent DMAC news
All market newsNo ticker-linked stories are in the current archive.